Related by context. Frequent words. (Click for all words.) 72 CMV vaccine 68 Initiates Phase II 68 R sorafenib tablets 67 Panzem R NCD 67 HGS ETR2 67 ZFP Therapeutics 67 VEGFR2 inhibitor 66 Darinaparsin 66 Protexia R 66 preclinical efficacy 65 Panzem R 65 Phase Ib II 65 Meets Primary Endpoint 65 GVAX R 65 Allovectin 7 R 65 GRNVAC1 65 Cethromycin 65 BioVant 65 huC# DM4 65 Respiratory Syncytial Virus RSV 65 elotuzumab 65 HuMax EGFr 64 Shigamabs ® 64 RGB # 64 Valortim R 64 Golimumab 64 Diamyd ® 64 HPV cervical cancer 64 BZL# 64 live attenuated influenza 64 BiTE R 64 Romidepsin 64 PEG SN# 64 Phase Ib IIa 64 Allovectin 7 ® 64 GVAX cancer 64 CR# vcMMAE 64 DDP# 64 2 methoxyestradiol 64 inflammatory autoimmune diseases 64 Belimumab 64 Sapacitabine 64 Atopic Dermatitis 63 PRT# 63 TLR9 agonist 63 refractory chronic lymphocytic 63 recurrent glioblastoma multiforme 63 liposomal formulation 63 ROTATEQ 63 targeting CD# 63 Factor VIIa 63 prophylactic vaccine 63 NEUMUNE 63 TOLAMBA 63 ALN TTR# 63 Traficet EN 63 Initiate Phase 63 forodesine 63 CCX# 63 RiVax ™ 63 IMC #B 63 Nanobody 62 SAR# [004] 62 DermaVir 62 pafuramidine 62 oral deforolimus 62 Recombinant Human 62 TELINTRA 62 Veronate 62 KRN# 62 Azedra 62 ganetespib 62 Aurexis 62 delafloxacin 62 immune modulating 62 Tesetaxel 62 AEG# 62 highly immunogenic 62 Epratuzumab 62 hepatitis C HCV 62 Pivotal Phase III 62 Ketotransdel 62 Chemophase 62 nasal powder 62 MOZOBIL 62 Phase III Clinical Trial 62 Clinical Trial Results 62 Genasense ® 62 Alinia 62 Presents Positive 62 proteasome inhibitor 62 Pivotal Phase 62 Metastatic Melanoma 62 Tarvacin TM 62 ALN TTR 62 CORT # 62 investigational therapies 61 talactoferrin 61 Daclizumab 61 CEQ# 61 deforolimus